Comprehensive molecular characterization of gastric adenocarcinoma
Adam Joel Bass, Vésteinn Thórsson, Ilya Shmulevich C et al. · Nature · 2014
Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein–Barr virus, which display recurrent PIK3CA mutations, extreme DNA hypermethylation, and amplification of JAK2, CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of RHOA or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roadmap for patient stratification and trials of targeted therapies. The Cancer Genome Atlas reports on molecular evaluation of 295 primary gastric adenocarcinomas and proposes a new classification of gastric cancers into 4 subtypes, which should help with clinical assessment and trials of targeted therapies. This contribution from The Cancer Genome Atlas (TCGA) project describes the molecular evaluation of 295 primary gastric adenocarcinomas. Based on the results, the authors propose a novel classification separating gastric cancers into four subtypes according to: Epstein–Barr virus positive status, microsatellite instability, chromosomal instability or genomic stability. Given the histologic and etiologic heterogeneity of gastric cancer identification of these subtypes, using a schema that can readily be applied to patient samples should help with patient stratification and trials of targeted therapies.
Cited by 6,466 works. doi:10.1038/nature13480 Open-access PDF
Authors
- Adam Joel Bass
- Vésteinn Thórsson
- Ilya Shmulevich C
- Sheila M. Reynolds
- Michael Miller
- Brady M. Bernard
- Vésteinn Thórsson
- Lisa E. Iype
- Roger Kramer
- Richard Kreisberg
- Hector Rovira
- Natalie Tasman
- Toshinori Hinoue
- Peter W. Laird
- Hui Shen
- Daniel J. Weisenberger
- Moiz Bootwalla
- Phillip H. Lai
- Timothy J. Triche
- David Van Den Berg
References
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMA
- Comprehensive molecular characterization of human colon and rectal cancer
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- WHO Classification of Tumours of the Digestive System
- Integrated genomic characterization of endometrial carcinoma
- Helicobacter pylori Infection and the Development of Gastric Cancer
- Cell Migration: Integrating Signals from Front to Back
- The STATs of cancer — new molecular targets come of age
- PID: The Pathway Interaction Database